Pages that link to "Q53329957"

The following pages link to Distinct ErbB-2 coupled signaling pathways promote mammary tumors with unique pathologic and transcriptional profiles. (Q53329957):

Displaying 19 items.

• Contribution of CXCL12 secretion to invasion of breast cancer cells. (Q22000754) (← links)
• ShcA signalling is essential for tumour progression in mouse models of human breast cancer (Q28590157) (← links)
• Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms (Q30457681) (← links)
• A genomic analysis of mouse models of breast cancer reveals molecular features of mouse models and relationships to human breast cancer (Q33835581) (← links)
• Oncogenes and tumor suppressor genes (Q34149922) (← links)
• Abl Kinases Are Required for Invadopodia Formation and Chemokine-induced Invasion (Q34401096) (← links)
• Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines (Q34760593) (← links)
• Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer. (Q34939322) (← links)
• Fc-DIRECTED ANTIBODY CONJUGATION OF MAGNETIC NANOPARTICLES FOR ENHANCED MOLECULAR TARGETING. (Q35018391) (← links)
• Perhexiline promotes HER3 ablation through receptor internalization and inhibits tumor growth (Q35174240) (← links)
• ErbB-2 signals through Plexin-B1 to promote breast cancer metastasis (Q35858100) (← links)
• Loss of one Tgfbr2 allele in fibroblasts promotes metastasis in MMTV: polyoma middle T transgenic and transplant mouse models of mammary tumor progression (Q36026081) (← links)
• Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasis (Q36311874) (← links)
• Signaling through ShcA is required for transforming growth factor beta- and Neu/ErbB-2-induced breast cancer cell motility and invasion (Q36710875) (← links)
• The nuclear receptor coactivator amplified in breast cancer-1 is required for Neu (ErbB2/HER2) activation, signaling, and mammary tumorigenesis in mice. (Q36811130) (← links)
• Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response (Q36863413) (← links)
• PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis (Q37254063) (← links)
• Novel strategies to augment genetically delivered immunotoxin molecular therapy for cancer therapy (Q39848249) (← links)
• β-arrestin deficiency protects against pulmonary fibrosis in mice and prevents fibroblast invasion of extracellular matrix (Q42734045) (← links)